在血液透析中应用ES-DMA-CPC进行综合分子分析:专注于β2-微型血球蛋白
Alice Chinghsuan Chang1, Kuan-Hung Liu2,3, Pi-Ju Fu1
1Center for Measurement Standards, Industrial Technology Research Institute, Hsinchu 30011, Taiwan.
ACS omega
|October 13, 2025
概括
一种新的无抗体方法准确地测量了血液透析患者的尿素毒素. 这种电子喷雾差分移动性分析仪与凝结粒子计数器 (ES-DMA-CPC) 相结合,为临床毒素分析提供了具有成本效益的替代方案.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分析化学 分析化学
- 生物医学工程 生物医学工程
背景情况:
- 中大尺寸的尿素毒素与血液透析患者的不良结果相关.
- 目前的量化方法依赖于昂贵的免疫学分析,限制了广泛的临床使用.
- 需要具有成本效益的,无抗体的方法来分析尿素毒素.
研究的目的:
- 开发和验证一种无抗体的分析方法,用于量化血液透析中中大尺寸的尿素毒素.
- 根据已确定的临床标准评估拟议方法的性能.
- 探索该方法用于全面分子分析和透析器性能评估的潜力.
主要方法:
- 使用了一种电子喷雾差分移动性分析仪与凝结粒子计数器 (ES-DMA-CPC) 相结合.
- 该方法用于分析血液透析患者消耗透析液中的尿素毒素.
- 通过比较与酶相关免疫吸收试验 (ELISA) 和免疫度测试的结果来评估性能.
主要成果:
- 通过ES-DMA-CPC方法,证明了与ELISA对β2-微球蛋白量化的高相关性.
- 消耗透析液分析结果与基于血清的免疫度测量有很强的一致性.
- 该方法成功量化了广泛的分子重量范围 (2.5-180 kDa) 中的分子.
结论:
- 开发的无抗体ES-DMA-CPC方法为尿素毒素分析提供了一种可靠的,可能更容易获得的方法.
- 这种技术为监测患者的分子形状和评估透析器效率提供了有价值的工具.
- 这些发现表明,在临床脏病学环境中,它是当前昂贵的免疫学方法的有希望的替代品.
更多相关视频
09:05Methylation Specific Multiplex Droplet PCR using Polymer Droplet Generator Device for Hematological Diagnostics
Published on: June 29, 2020
5.6K
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
1.0K
相关概念视频
Dialysis
1.6K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
403
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
403
Hemodialysis II: Procedure and Complications
644
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
644
Hemodialysis I: Introduction
1.3K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.3K
